Stockreport

Immunovant To Report Fourth Quarter And Full Year 2022 Financial Results On June 8, 2022 [TheStreet.com]

Immunovant, Inc.  (IMVT) 
PDF NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with [Read more]